APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Canine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Canine Influenza Vaccine Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchCanine Influenza Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Influenza Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Canine Influenza Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canine Influenza Vaccine include Bharat Biotech, CNBG, CSL Limited, LIAONING CHENGDA, Merck Animal Health, GSK, Roche, Novartis and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Canine Influenza Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Canine Influenza Vaccine market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Canine Influenza Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Canine Influenza Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Canine Influenza Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Canine Influenza Vaccine Market by Company

Bharat Biotech

CNBG

CSL Limited

LIAONING CHENGDA

Merck Animal Health

GSK

Roche

Novartis

Zoetis

Canine Influenza Vaccine Segment by Type

H3N2 Vaccine

H3N8 Vaccine

Canine Influenza Vaccine Segment by Application

Vaccination Clinic

Pet Hospital

Others

Canine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of H3N2 Vaccine Table 2. Major Company of H3N8 Vaccine Table 3. Global Canine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 5. Global Canine Influenza Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Canine Influenza Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Canine Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 10. Global Canine Influenza Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Canine Influenza Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Canine Influenza Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Canine Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 15. North America Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 17. Europe Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 21. Latin America Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Canine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Canine Influenza Vaccine Industry Trends Table 25. Canine Influenza Vaccine Industry Drivers Table 26. Canine Influenza Vaccine Industry Opportunities and Challenges Table 27. Canine Influenza Vaccine Industry Restraints Table 28. Global Canine Influenza Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Canine Influenza Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Canine Influenza Vaccine Sales by Company (2021-2026) & (W Units) Table 31. Global Canine Influenza Vaccine Sales Share by Company (2021-2026) Table 32. Global Canine Influenza Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Canine Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Canine Influenza Vaccine Major Company Production Sites and Headquarters Table 35. Global Canine Influenza Vaccine Company, Product Type & Application Table 36. Global Canine Influenza Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Canine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Canine Influenza Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 41. Global Canine Influenza Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Canine Influenza Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Canine Influenza Vaccine Sales by Region (2027-2032) & (W Units) Table 46. Global Canine Influenza Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Canine Influenza Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Canine Influenza Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Canine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 52. Global Canine Influenza Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Canine Influenza Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Canine Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 57. Global Canine Influenza Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Canine Influenza Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Canine Influenza Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Canine Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 62. North America Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 64. Europe Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 68. Latin America Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Canine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Canine Influenza Vaccine Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. CNBG Company Information Table 77. CNBG Business Overview Table 78. CNBG Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CNBG Canine Influenza Vaccine Product Portfolio Table 80. CNBG Recent Development Table 81. CSL Limited Company Information Table 82. CSL Limited Business Overview Table 83. CSL Limited Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CSL Limited Canine Influenza Vaccine Product Portfolio Table 85. CSL Limited Recent Development Table 86. LIAONING CHENGDA Company Information Table 87. LIAONING CHENGDA Business Overview Table 88. LIAONING CHENGDA Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio Table 90. LIAONING CHENGDA Recent Development Table 91. Merck Animal Health Company Information Table 92. Merck Animal Health Business Overview Table 93. Merck Animal Health Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck Animal Health Canine Influenza Vaccine Product Portfolio Table 95. Merck Animal Health Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GSK Canine Influenza Vaccine Product Portfolio Table 100. GSK Recent Development Table 101. Roche Company Information Table 102. Roche Business Overview Table 103. Roche Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Roche Canine Influenza Vaccine Product Portfolio Table 105. Roche Recent Development Table 106. Novartis Company Information Table 107. Novartis Business Overview Table 108. Novartis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Novartis Canine Influenza Vaccine Product Portfolio Table 110. Novartis Recent Development Table 111. Zoetis Company Information Table 112. Zoetis Business Overview Table 113. Zoetis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Zoetis Canine Influenza Vaccine Product Portfolio Table 115. Zoetis Recent Development Table 116. North America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. North America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 118. North America Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Canine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 120. North America Canine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Canine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Canine Influenza Vaccine Market Share by Country (2021-2026) Table 124. North America Canine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Canine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Europe Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 128. Europe Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Canine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 130. Europe Canine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Canine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Canine Influenza Vaccine Market Share by Country (2021-2026) Table 134. Europe Canine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Canine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 138. Asia-Pacific Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Canine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 140. Asia-Pacific Canine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Canine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Canine Influenza Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Canine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Canine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Latin America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 148. Latin America Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Canine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 150. Latin America Canine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Canine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Canine Influenza Vaccine Market Share by Country (2021-2026) Table 154. Latin America Canine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Canine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 158. Middle East and Africa Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Canine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 160. Middle East and Africa Canine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Canine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Canine Influenza Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Canine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Canine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Canine Influenza Vaccine Distributors List Table 169. Canine Influenza Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Canine Influenza Vaccine Image Figure 2. Global Canine Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Canine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 5. H3N2 Vaccine Image Figure 6. Global H3N2 Vaccine Sales YoY Growth (2021-2032) & (W Units) Figure 7. H3N8 Vaccine Image Figure 8. Global H3N8 Vaccine Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Canine Influenza Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Canine Influenza Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Canine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Canine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Canine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Canine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Canine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Canine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Canine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Canine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Canine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Canine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Canine Influenza Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Vaccination Clinic Image Figure 24. Global Vaccination Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 25. Pet Hospital Image Figure 26. Global Pet Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Canine Influenza Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Canine Influenza Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Canine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Canine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Canine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Canine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Canine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Canine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Canine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Canine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Canine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Canine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Canine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Canine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Canine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Canine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Canine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Canine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Canine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Canine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Canine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Canine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Canine Influenza Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Canine Influenza Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • H3N2 Vaccine
  • H3N8 Vaccine
Applications
  • Vaccination Clinic
  • Pet Hospital
  • Others
Companies covered
  • Bharat Biotech
  • CNBG
  • CSL Limited
  • LIAONING CHENGDA
  • Merck Animal Health
  • GSK
  • Roche
  • Novartis
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canine Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Canine Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Canine Influenza Vaccine Market by Type
  6. 1.3.1 H3N2 Vaccine
  7. 1.3.2 H3N8 Vaccine
  8. 1.4 Global Canine Influenza Vaccine Market Size by Type
  9. 1.4.1 Global Canine Influenza Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Canine Influenza Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Canine Influenza Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Canine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Canine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Canine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Canine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Canine Influenza Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Canine Influenza Vaccine Industry Trends
  2. 2.2 Canine Influenza Vaccine Industry Drivers
  3. 2.3 Canine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Influenza Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Canine Influenza Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Canine Influenza Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Canine Influenza Vaccine Price (2021-2026)
  4. 3.4 Global Canine Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canine Influenza Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Canine Influenza Vaccine Company, Product Type & Application
  7. 3.7 Global Canine Influenza Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canine Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canine Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canine Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Canine Influenza Vaccine Regional Status and Outlook
  1. 4.1 Global Canine Influenza Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Canine Influenza Vaccine Historic Market Size by Region
  3. 4.2.1 Global Canine Influenza Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Canine Influenza Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Canine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Canine Influenza Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Canine Influenza Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Canine Influenza Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Canine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Canine Influenza Vaccine by Application
  1. 5.1 Canine Influenza Vaccine Market by Application
  2. 5.1.1 Vaccination Clinic
  3. 5.1.2 Pet Hospital
  4. 5.1.3 Others
  5. 5.2 Global Canine Influenza Vaccine Market Size by Application
  6. 5.2.1 Global Canine Influenza Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Canine Influenza Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Canine Influenza Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Canine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Canine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Canine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Canine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Canine Influenza Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 CNBG
  8. 6.2.1 CNBG Company Information
  9. 6.2.2 CNBG Business Overview
  10. 6.2.3 CNBG Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CNBG Canine Influenza Vaccine Product Portfolio
  12. 6.2.5 CNBG Recent Developments
  13. 6.3 CSL Limited
  14. 6.3.1 CSL Limited Company Information
  15. 6.3.2 CSL Limited Business Overview
  16. 6.3.3 CSL Limited Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Limited Canine Influenza Vaccine Product Portfolio
  18. 6.3.5 CSL Limited Recent Developments
  19. 6.4 LIAONING CHENGDA
  20. 6.4.1 LIAONING CHENGDA Company Information
  21. 6.4.2 LIAONING CHENGDA Business Overview
  22. 6.4.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
  24. 6.4.5 LIAONING CHENGDA Recent Developments
  25. 6.5 Merck Animal Health
  26. 6.5.1 Merck Animal Health Company Information
  27. 6.5.2 Merck Animal Health Business Overview
  28. 6.5.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
  30. 6.5.5 Merck Animal Health Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Canine Influenza Vaccine Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roche Canine Influenza Vaccine Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis Canine Influenza Vaccine Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Zoetis
  50. 6.9.1 Zoetis Company Information
  51. 6.9.2 Zoetis Business Overview
  52. 6.9.3 Zoetis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis Canine Influenza Vaccine Product Portfolio
  54. 6.9.5 Zoetis Recent Developments
7 North America by Country
  1. 7.1 North America Canine Influenza Vaccine Sales by Country
  2. 7.1.1 North America Canine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Canine Influenza Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Canine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Canine Influenza Vaccine Market Size by Country
  6. 7.2.1 North America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Canine Influenza Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Canine Influenza Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Canine Influenza Vaccine Sales by Country
  2. 8.1.1 Europe Canine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Canine Influenza Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Canine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Canine Influenza Vaccine Market Size by Country
  6. 8.2.1 Europe Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Canine Influenza Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Canine Influenza Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Canine Influenza Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Canine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Canine Influenza Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Canine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Canine Influenza Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Canine Influenza Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Canine Influenza Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Canine Influenza Vaccine Sales by Country
  2. 10.1.1 South America Canine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Canine Influenza Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Canine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Canine Influenza Vaccine Market Size by Country
  6. 10.2.1 South America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Canine Influenza Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Canine Influenza Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Canine Influenza Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Canine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Canine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Canine Influenza Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Canine Influenza Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Canine Influenza Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Canine Influenza Vaccine Value Chain Analysis
  2. 12.1.1 Canine Influenza Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Canine Influenza Vaccine Production Mode & Process
  7. 12.2 Canine Influenza Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Canine Influenza Vaccine Distributors
  10. 12.2.3 Canine Influenza Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst